We are live on ! Find out more
AEMD icon

Aethlon Medical
AEMD

19 hedge funds and large institutions have $1.21M invested in Aethlon Medical in 2025 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

0.06% more ownership

Funds ownership: 0.14% → 0.2% (+0.06%)

5% less funds holding

Funds holding: 20 → 19 (-1)

12% less capital invested

Capital invested by funds: $1.38M → $1.21M (-$172K)

17% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 6

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
19
Holders Change
-1
Holders Change %
-5%
% of All Funds
0.25%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
5
Increased
5
Reduced
2
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
AC
Armistice Capital
New York
+$831K
2
IC
Ikarian Capital
Texas
+$279K
3
BFM
Boothbay Fund Management
New York
+$82.7K
4
TSS
Two Sigma Securities
New York
+$18.3K
5
HF
HRT Financial
New York
+$11.6K

Top Sellers

1
UBS Group
UBS Group
Switzerland
-$106K
2
VF
Virtu Financial
New York
-$45.3K
3
SCA
Sassicaia Capital Advisers
New York
-$31K
4
Renaissance Technologies
Renaissance Technologies
New York
-$25.2K
5
SRL
Scientech Research LLC
New Jersey
-$19.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$511K +$831K +17,849 New
IC
2
Ikarian Capital
Texas
$440K +$279K +5,991 +64%
BFM
3
Boothbay Fund Management
New York
$128K +$82.7K +1,776 +66%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$44.5K +$8.1K +174 +13%
UBS Group
5
UBS Group
Switzerland
$23.9K -$106K -2,286 -73%
TSS
6
Two Sigma Securities
New York
$11.2K +$18.3K +392 New
AFGAS
7
Allegiance Financial Group Advisory Services
Virginia
$10.7K – – –
Two Sigma Investments
8
Two Sigma Investments
New York
$8.13K +$93 +2 +0.7%
Vanguard Group
9
Vanguard Group
Pennsylvania
$7.6K – – –
HF
10
HRT Financial
New York
$7K +$11.6K +249 New
VF
11
Virtu Financial
New York
$6K -$45.3K -972 -83%
Citadel Advisors
12
Citadel Advisors
Florida
$5.06K +$8.24K +177 New
BBA
13
Baader Bank Aktiengesellschaft
Germany
$3.27K +$6.71K +144 New
BlackRock
14
BlackRock
New York
$2.63K – – –
Group One Trading
15
Group One Trading
Illinois
$436 – – –
Wells Fargo
16
Wells Fargo
California
$76 – – –
Osaic Holdings
17
Osaic Holdings
Arizona
$53 – – –
Bank of America
18
Bank of America
North Carolina
$44 +$47 +1 +100%
Morgan Stanley
19
Morgan Stanley
New York
$32 – – –
TRCT
20
Tower Research Capital (TRC)
New York
$14 -$2.23K -48 Closed
SS
21
SBI Securities
Japan
$14 -$466 -10 Closed
BCWM
22
Bartlett & Co Wealth Management
Ohio
$9 – – –
TC
23
Truvestments Capital
Florida
$2 – – –
AF
24
Allworth Financial
California
$1 – – –
SCA
25
Sassicaia Capital Advisers
New York
– -$31K -450 Closed
1
2

AEMD Hedge Fund Activity: Q1 2025 in Review

19 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q1 2025, worth a combined $1.21M — down 12% from $1.38M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of AEMD and 5 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 5 added.

The largest buyer was Armistice Capital, opening a new position worth an estimated $831K. The largest seller was UBS Group, cutting an estimated $106K.

  • 19 institutional investors held Aethlon Medical (AEMD) as of Q1 2025, down from 20 in Q4 2024.
  • Funds reported $1.21M of Aethlon Medical stock for Q1 2025, down 12% quarter-over-quarter.
  • 5 funds opened new Aethlon Medical positions in Q1 2025 and 6 closed out, a net change of -1 holder.
  • The largest Aethlon Medical buyer in Q1 2025 was Armistice Capital, an estimated $831K added.
  • The largest Aethlon Medical seller in Q1 2025 was UBS Group, an estimated $106K sold.

Based on aggregated 13F filings for Q1 2025.